ENHANCEMENT OF PROSTACYCLIN PRODUCTION IN CULTURED BOVINE AORTIC ENDOTHELIAL-CELLS BY OXIDIZED GLYCATED LOW-DENSITY-LIPOPROTEIN

被引:4
作者
KOBAYASHI, K
WATANABE, J
UMEDA, F
TANIGUCHI, S
MASAKADO, M
YAMAUCHI, T
NAWATA, H
机构
[1] The Third Department of Internal Medicine, Faculty of Medicine, Kyushu University, Higashi-ku, Fukuoka, 812
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 1995年 / 52卷 / 04期
关键词
D O I
10.1016/0952-3278(95)90048-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidized low-density lipoprotein (oLDL) is implicated in the pathogenesis of atherosclerosis. The serum concentration of glycated LDL (gLDL) is increased in diabetics, and it is possible that oxidative modification of gLDL contributes to the increased incidence of atherosclerosis associated with diabetes. The mechanism and effect on prostacyclin (PGI(2)) production by cultured bovine aortic endothelial cells of oxidized glycated LDL (ogLDL) prepared in vitro have now been examined. Glycation of LDL was performed by incubating LDL with 20 mM glucose for 3 days, ogLDL was then prepared by incubation of gLDL with 1 mu M CuSO4 for 12 h. Both the electrophoretic mobility and the thiobarbituric acid reactive substance content of ogLDL were greater than those of native LDL (nLDL) or gLDL. Binding, cell-association, and degradation of ogLDL in endothelial cells were significantly greater than those of nLDL and gLDL. The stimulatory effect of ogLDL on PGI(2) production was significantly greater than that of nLDL or gLDL; this effect was dose dependent. Both cell-association and the stimulatory effect on PGI(2) production of oLDL were dependent on the extent of oxidation in a biphasic manner. Endothelial cells thus appear to protect against atherosclerosis by removing atherogenic lipoproteins and by producing PGI(2).
引用
收藏
页码:263 / 270
页数:8
相关论文
共 49 条
[1]   INCREASE IN THE GLUCOSYLATED FORM OF ERYTHROCYTE CU-ZN-SUPEROXIDE DISMUTASE IN DIABETES AND CLOSE ASSOCIATION OF THE NONENZYMATIC GLUCOSYLATION WITH THE ENZYME-ACTIVITY [J].
ARAI, K ;
IIZUKA, S ;
TADA, Y ;
OIKAWA, K ;
TANIGUCHI, N .
BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 924 (02) :292-296
[2]   MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN STIMULATES MONOCYTE ENDOTHELIAL INTERACTIONS [J].
BERLINER, JA ;
TERRITO, MC ;
SEVANIAN, A ;
RAMIN, S ;
KIM, JA ;
BAMSHAD, B ;
ESTERSON, M ;
FOGELMAN, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1260-1266
[3]  
BIERMAN EL, 1974, CIRC RES, V35, P136, DOI 10.1161/01.RES.35.1.136
[4]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[5]  
Buege J A, 1978, Methods Enzymol, V52, P302
[6]  
CATHCART MK, 1991, J LIPID RES, V32, P63
[7]  
CHAUTAN M, 1993, J LIPID RES, V34, P101
[8]   MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN INDUCES MONOCYTE CHEMOTACTIC PROTEIN-1 IN HUMAN ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE CELLS [J].
CUSHING, SD ;
BERLINER, JA ;
VALENTE, AJ ;
TERRITO, MC ;
NAVAB, M ;
PARHAMI, F ;
GERRITY, R ;
SCHWARTZ, CJ ;
FOGELMAN, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) :5134-5138
[9]  
GALLE J, 1990, EICOSANOIDS, V3, P81
[10]   MORBIDITY AND MORTALITY IN DIABETICS IN FRAMINGHAM POPULATION - 16-YEAR FOLLOW-UP STUDY [J].
GARCIA, MJ ;
MCNAMARA, PM ;
GORDON, T ;
KANNELL, WB .
DIABETES, 1974, 23 (02) :105-111